Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.45 |
| ▸ | RARB | P10826 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8533362 | 0.82 | RARB (0.58) | NPC1RAB9ANR5A1RARBCYP3A4 | |
| SCHEMBL8532324 | 0.82 | RARB (0.58) | NPC1RAB9ANR5A1RARBCYP3A4 | |
| SCHEMBL8759014 | 0.82 | RARB (0.58) | NPC1RAB9ANR5A1RARBCYP3A4 | |
| SCHEMBL7136341 | 0.82 | PTPN11 (0.50) | PTPN11NPC1RAB9ANR5A1RARB | |
| SCHEMBL4335776 | 0.81 | PTPN11 (0.46) | PTPN11NPC1RAB9ANR5A1RARB | |
| SCHEMBL9561907 | 0.81 | NR5A1 (0.61) | NPC1RAB9ANR5A1 | |
| SCHEMBL2553422 | 0.81 | NR5A1 (0.61) | NPC1RAB9ANR5A1 | |
| SCHEMBL11144854 | 0.81 | NR5A1 (0.61) | NPC1RAB9ANR5A1 | |
| SCHEMBL14064703 | 0.81 | NR5A1 (0.61) | NPC1RAB9ANR5A1 | |
| SCHEMBL4809789 | 0.81 | NR5A1 (0.61) | NPC1RAB9ANR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0975710-B2 | POLYMER ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2009-06-10 | — | — | EP | claimed |
| US-6509507-B2 | Reacting a 6-membered aromatic ring with 1,4- position ester or benzylic OH groups with a second aromatic in a palladium catalyzed cross-coupling; electroluminescence | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 2003-01-21 | — | — | US | disclosed |
| US-6458909-B1 | SOLID-STATE LIGHT SOURCES FOR A SERIES OF APPLICATIONS, PREDOMINANTLY IN THE FIELD OF DISPLAY ELEMENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | disclosed |
| US-20020087030-A1 | Polymerizable biaryls, process for their preparation and their use | MERCK PATENT GMBH (DE) | 2002-07-04 | — | — | US | disclosed |
| EP-0944569-B1 | POLYMERIZABLE BIARYLS, METHOD FOR THE PRODUCTION AND USE THEREOF | CELANESE VENTURES GMBH (DE) | 2002-04-10 | — | — | EP | disclosed |
| EP-0944663-B1 | ARYL-SUBSTITUTED POLY(p-ARYLENE VINYLENES), METHOD FOR THE PRODUCTION AND USE THEREOF IN ELECTROLUMINESCENT COMPONENTS | CELANESE VENTURES GMBH (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-6323373-B1 | USED TO OBTAIN POLYMERS WHICH ARE USED AS ELECTROLUMINESCENCE MATERIALS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 2001-11-27 | — | — | US | disclosed |
| EP-0944569-A1 | POLYMERIZABLE BIARYLS, METHOD FOR THE PRODUCTION AND USE THEREOF | Aventis Research & Technologies GmbH & Co. KG (DE) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998025874-A1 | POLYMERIZABLE BIARYLS, METHOD FOR THE PRODUCTION AND USE THEREOF | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020087030-A1 | Polymerizable biaryls, process for their preparation and their use | PAH, TYR, PAICS | PTPN11 4853/4885NPC1 4596/4885RAB9A 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.